Vascular Factors in Alzheimer's Disease

21 Apr 2004

but not by apoptosis (we discussed this in Science/Nature several years ago, see Perry et al 1998 and

Protein Misfolding: An Unfolding Series of Discussions

09 Jun 2004

decreases in proteasome activity in AD (Keller et al., 2000 and Keck et al., 2003, but has anyone looked

Cast Call for Players: Healthy Aging Through Lean Living

17 Aug 2004

was no different than that of the animals fed ad libitum every day (see Anson et al., 2003). Howard

Memantine: Implications for Treating Alzheimer's

29 Sep 2004

effects (see Orgogozo et al., 2002 and Wilcock et al., 2002). John C. Morris Bengt, Lon, Steve, Gabrielle,

Role and Control of Metal-Mediated Fibril Toxicity

20 Dec 2004

protection against the Aβ toxicity (see Lovell et al., 1998). All told, the evidence points to iron- or

Imaging in Alzheimer's Disease: The Current State of Affairs

27 Apr 2005

samples). (See Kung et al., 2002.) The data look good but we are not ready to publish yet. Bill, what's

Making a BioMark on Alzheimer Disease

01 Jun 2005

milestone paper by Pratico et al., 2001 on isoprostanes in AD and also papers by Montine et al., 2005 and

Now You See Them, Now You Don't: The Amyloid Channel Hypothesis

16 Jun 2005

et al., 1998; Lin et al., 1999; Lin et al., 2001; Bhatia et al., 2000). Tom Fagan So how does the

100 Questions and Answers About Alzheimer's Disease

01 Jul 2005

regarding your peptide inhibitor (see Sadowski et al., 2004)? In your paper, your peptide inhibits the

Insulin Resistance: A Common Axis Linking Alzheimer's, Depression and Metabolism?

06 Jul 2005

are very interesting! Natalie Rasgon Currently, there are studies (see, for example, Benedict et al.,

Could a New Down Syndrome Mouse Model Also Be Useful for Alzheimer Research?

14 Oct 2005

aged 78 postmortem, did not have APP pathology (see Prasher et al., 1998). She was trisomic for the

Ceramide and Cholesterol: Possible Connections Between Normal Aging of the Brain and Alzheimer’s Disease

15 Oct 2005

(see Constantini et al., 2005) where we show that ceramide levels increase during aging in the brain of

Lost in Translation? Charting the Course in Preclinical Therapeutic Development: A Panel Discussion

15 Oct 2005

(Lopez et al., 2005). Eli Michaelis Thanks, June. Jens Eckstein The problem is that adoption of

Reducing the Risk of Alzheimer Disease

23 Dec 2005

deposition in APP mice, a result observed in three separate laboratories (see Patel et al., 2005 and Wang et

Webinar: Axonopathy in Mouse Models of AD

30 Nov 2006

transgenic mouse models (Casas et al., 2004). Some neurodegenerative diseases including AD and amyotrophic